Sofinnova Capital VI FCPR 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-15 4:46 pm Sale | 2021-05-20 | 13D | ASCENDIS PHARMA A/S SPONSORED ASND | Sofinnova Capital VI FCPR | 4,978,993 9.700% | -819,849 (-14.14%) | Filing |